HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

A rare case of Epstein-Barr virus-induced Bell palsy in an 18-year-old highlights the need for EBV testing in sudden facial ...

Pregnant women with measles are at increased risk of its complications, which include pneumonia, hepatitis, and ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

A second study reported the twice-a-year injections lowered the HIV infection rate by 96% in groups of cisgender men and gender-diverse people in the U.S., Argentina, Brazil, Mexico, Peru, South ...

The DOH has actually observed this shift in the age demographic of HIV diagnoses over the past two decades. Since 2006, the most affected group has moved from 35-49 years old to 25-34 years old ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...